Because cancer aggressiveness depends also on the ability to induce proliferation and migration we further examined the effects of sera from MBP-1-ve patients versus MBP-1+ve patients to stimulate proliferation and migration in the MDA-MB-231 breast cancer cells. Here, ENO1 is linked to cancer.